Cart
sales@molnova.com
Anlotinib Dihydrochloride
CAS No. 1360460-82-7
Anlotinib Dihydrochloride( Anlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride )
Catalog No. M19393 CAS No. 1360460-82-7
Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAnlotinib Dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.
-
DescriptionAnlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration anlotininib targets multiple RTKs including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.
-
In Vitro——
-
In Vivo——
-
SynonymsAnlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR2| VEGFR3|c-Kit
-
Research AreaCancer
-
IndicationNon-small cell lung Cancer
Chemical Information
-
CAS Number1360460-82-7
-
Formula Weight480.36
-
Molecular FormulaC23H24Cl2FN3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:87 mg/mL(181.1 mM)
-
SMILESCc1cc2c([nH]1)ccc(c2F)Oc1c2cc(c(cc2ncc1)OCC1(CC1)N)OC.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yongkun Sun et al. Safety pharmacokinetics and antitumor properties of anlotinib an oral multi-target tyrosine kinase inhibitor in patients with advanced refractory solid tumors. Journal of Hematology & Oncology20169:105
molnova catalog
related products
-
Telatinib
An orally active, small molecule inhibitor of VEGFR-2 (IC50=6 nM), VEGFR-3 (IC50=4 nM), PDEGFRα (IC50=15 nM) and c-Kit (IC50=1 nM) in biochemical assays.
-
Tivozanib
A highly potent inhibitor of pan-VEGFR with IC50s of 60/6.5/15 nM for VEGFR1/2/3.
-
Takeda-6d
Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively.
